Bio
As Scientific Director, Farhad Islami, MD, PhD, leads the Cancer Disparity Research team in the Data Science research group at the American Cancer Society (ACS). He primarily conducts transdisciplinary research to identify individual, social, biological, structural, and system level determinants of health and to estimate the contribution of each to cancer disparities. The objective of this work is to inform cancer care delivery and public policy. He also conducts and collaborates on research focused on cancer surveillance and risk factors.
Areas of Interest
- Cancer Prevention
- Epidemiology
- Health Disparities
Education
- PhD, King’s College London, University of London, United Kingdom
- MD, Tehran University of Medical Sciences, Tehran, Iran
Affiliations
Islami’s research focuses on quantifying the impact of factors that contribute to cancer disparities across the cancer continuum. He has also conducted extensive research on the risk factors of cancer that are potentially modifiable.
As a member of the International Agency for Research on Cancer (IARC) team, Islami has been in multiple IARC Monographs and Handbooks and an IARC Monograph Working Group Member for Monograph volume 116, Carcinogenicity of Drinking Coffee, Mate, and Very Hot Beverages.
Full publication list: